Kielkopf, M. C., Göcmen, J., Venzin, S. B., Steinauer, F., Branca, M., Boronylo, A., . . . Beyeler, M. (2025). Anticoagulant versus antiplatelet treatment for secondary stroke prevention in patients with active cancer. Frontiers in neurology, 16, 1530775. https://doi.org/10.3389/fneur.2025.1530775
Chicago-Zitierstil (17. Ausg.)Kielkopf, Moritz C., et al. "Anticoagulant Versus Antiplatelet Treatment for Secondary Stroke Prevention in Patients with Active Cancer." Frontiers in Neurology 16 (2025): 1530775. https://doi.org/10.3389/fneur.2025.1530775.
MLA-Zitierstil (9. Ausg.)Kielkopf, Moritz C., et al. "Anticoagulant Versus Antiplatelet Treatment for Secondary Stroke Prevention in Patients with Active Cancer." Frontiers in Neurology, vol. 16, 2025, p. 1530775, https://doi.org/10.3389/fneur.2025.1530775.